Table 1.
Baseline characteristics of patients included in the study
| Characteristic | Evaluable patients, n = 35 |
|---|---|
| Gender, n (%) | |
| Male | 24 (68.6) |
| Female | 11 (31.4) |
| Age at enrolment, years | 26.1 ± 14.4 |
| BMI, kg/m2 | 23.1 ± 4.7 |
| PID type at enrolment, n (%) | |
| CVID | 20 (57.1) |
| XLA | 9 (25.7) |
| ARA | 1 (2.9) |
| Othera | 5 (14.3) |
| Disease duration at enrolment, years | 10.2 ± 8.9 |
| Comorbidities at enrolment, n (%) | |
| Autoimmune disease | 3 (8.6) |
| Other PID-related pathologies | 12 (34.3) |
Values are presented as mean ± standard deviation unless otherwise stated
ARA autosomal recessive agammaglobulinemia, BMI body mass index, CVID common variable immunodeficiency, PID primary immunodeficiency, SD standard deviation, XLA X-linked agammaglobulinemia
aIgG subclass deficiency (n = 4) and DiGeorge syndrome (n = 1)